Current global surveillance data from the World Health Organization and CDC show no novel pathogen with sustained human-to-human transmission or pandemic potential emerging in 2026. Routine respiratory virus activity remains within seasonal baselines, with no confirmed outbreaks exceeding historical thresholds for novel strains. Trader consensus at 89 percent for “No” reflects this absence of early-warning signals such as rapid case growth, unusual severity, or zoonotic spillover events that historically precede pandemics. Ongoing genomic monitoring and international reporting systems continue to track variants of known viruses without identifying any candidate capable of meeting formal pandemic criteria by year-end. New data releases from WHO and CDC surveillance networks remain the next key checkpoints that could shift these market-implied odds.